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Despite an enormous interest in the role of extracellular vesicles, including exosomes, in cancer and their use
as biomarkers for diagnosis, prognosis, drug response and recurrence, there is no consensus on dependable
isolation protocols. We provide a comparative evaluation of 4 exosome isolation protocols for their usability,
yield and purity, and their impact on downstream omics approaches for biomarker discovery. OptiPrep density
gradient centrifugation outperforms ultracentrifugation and ExoQuick and Total Exosome Isolation pre-
cipitation in terms of purity, as illustrated by the highest number of CD63-positive nanovesicles, the highest
enrichment in exosomal marker proteins and a lack of contaminating proteins such as extracellular Argonaute-
2 complexes. The purest exosome fractions reveal a unique mRNA profile enriched for translation, ribosome,
mitochondrion and nuclear lumen function. Our results demonstrate that implementation of high purification
techniques is a prerequisite to obtain reliable omics data and identify exosome-specific functions and
biomarkers.
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T
umours are ecosystems characterized by an intense
communication between cancer cells and stro-
mal cells. These ecosystems establish para- and
endocrine- signalling networks that support invasive
growth and metastasis, and consist of soluble factors as
well as membrane-bound ligands and receptors, free or
enclosed in small extracellular vesicles (EVs), including
exosomes (1). Exosomes are bilayered and nm-sized
(50150 nm) EVs that express a characteristic set of
proteins [heat-shock protein (HSP)90a, HSP70, CD63,
Alix and TSG101] and are released by fusion of multi-
vesicular endosomes (MVE) with the plasma membrane
(2). The observation that exosomes contain not only
proteins but also RNA species promoted them as potential
powerful communicators in both local and distant tumour
ecosystems and caused a paradigm shift in current cancer
research (3). This is reflected in the rapid growth of the
number of publications, a trend driven by the growing
interest in revealing exosome functions and discovering
diagnostic, prognostic and therapeutic biomarkers.
One important challenge is the lack of standard
methods to obtain highly pure and well-characterized exo-
some populations. A literature search of full-text avail-
able research articles published in the years 20112013
with the key words ‘‘exosomes,’’ ‘‘cancer’’ and ‘‘human’’ re-
vealed that different methods are implemented to isolate
exosomes for functional studies and biomarker discovery,
including (differential) ultracentrifugation (UC) (56%), den-
sity gradient- or cushion-based UC (27%) and ExoQuickTM
precipitation (13%). Additionally, new methods are being

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commercialized, such as the Total Exosome IsolationTM
precipitation solution, and are finding their way to com-
mon practice. A robust method with the ability to
minimize co-isolating protein aggregates and other mem-
branous particles is a prerequisite to identify consistent
and biologically relevant exosome-specific functions and
biomarkers. Unfortunately, many studies fail to assess the
purity of isolated exosome populations before performing
functional assays or downstream omics approaches.
The current gold standard for exosome isolation is
differential UC, which, in its classical form, consists of
multiple centrifugation steps with increasing centrifugal
strength to sequentially pellet cells (300 g), microvesicles
(10,000 g) and exosomes (100,000 g) (4). Many variations
to these speeds are implemented in practice. Alternatively,
serial filtration through 0.45 and 0.2 mm filters is used
before exosome pelleting (4). Density gradientbased
isolation, using sucrose or iodixanol (OptiPrepTM), can
be applied to obtain more pure exosome preparations.
Recent reports encourage the use of iodixanol-based gra-
dients for improved separation of exosomes from viruses
and small apoptotic bodies (5). Also, unlike sucrose,
iodixanol is capable of forming iso-osmotic solutions at
all densities, thus better preserving the size of the vesicles
in the gradient (6). Therefore, in this study iodixanol
was chosen as gradient component instead of the more
conventionally used sucrose. In addition to these tradi-
tional isolation techniques, easy-to-use precipitation solu-
tions, such as ExoQuickTM and Total Exosome IsolationTM
(TEI), have been commercialized in the last few years with
no need for expensive equipment or technical know-how.
Although their mode-of-action has not been disclosed or
validated, these kits are commonly used.
In this study, we evaluate the impact of 4 isolation
methods (single-step and density-gradient UC-based
protocols, and two commercially available precipitation
solutionbased protocols) on yield, purity, size, morphol-
ogy and proteome and transcriptome content. We imple-
ment conditioned medium (CM) of a breast cancer cell
culture model that stably expresses Rab27B, a small
GTPase that recruits MVEs towards the plasma mem-
brane and thus drives exosome release in the extracellular
environment (7,8). We demonstrate that the choice of
isolation method severely impacts the purity and accord-
ingly the omics profiles of exosome populations. OptiPrepTM
density gradient UC outperforms the other 3 methods and
reveals a unique mRNA profile enriched for translation,
ribosome, mitochondrion and nuclear lumen function.
Materials and methods
Cell culture
The oestrogen receptor-positive human breast cancer cell
line MCF-7 (ATCC, Manassas, VA) was stably transfected
with either an empty peGFP-c1 vector (Clontech, Moun-
tain View, CA) (MCF-7 GFP) or the same vector contain-
ing a GFP-Rab27B fusion construct (MCF-7 Rab27B), as
described previously (9). The cell line was maintained in
Dulbecco’s minimal essential medium supplemented with
10% foetal bovine serum, 100 U/mL penicillin, 100 mg/mL
streptomycin and 1 mg/mL G418 (i.e. culture medium) and
incubated at 378C in 10% CO2 (Invitrogen, Carlsbad, CA).
Cell cultures were regularly tested and found negative for
mycoplasma contamination using the MycoAlert Myco-
plasma Detection Kit (Lonza, Verviers, Belgium) (10).
Antibodies and reagents
The following primary and secondary antibodies were
used for immunostaining: rabbit polyclonal anti-Ago2
(1:1,000) (ab32381, Abcam, Cambridge, UK), mouse
monoclonal anti-Alix (1:1,000) (2171, Cell Signaling,
Danvers, MA, USA), rabbit polyclonal anti-calreticulin
(1:1,000) (2891, Cell Signaling), mouse monoclonal
anti-CD63 clone MEM-259 (1:200) (ab8219, Abcam),
mouse monoclonal anti-GM130 (1:500) (610822, Becton
Dickinson, Franklin Lakes, NJ, USA), rabbit poly-
clonal anti-HSP70 (1:1,000) (EXOAB-HSP70A-1, System
Biosciences, Mountain View, CA, USA), rabbit poly-
clonal anti-HSP90a (1:500) (PA3-012, Thermo Scientific,
Erembodegem, Belgium), mouse monoclonal anti-PARP
(poly ADP ribose polymerase) clone 4C10-5 (1:1,000)
(556494, Becton Dickinson), rabbit polyclonal anti-PMP70
(1:2,000) (P0497, Sigma, Diegem, Belgium), rabbit mono-
clonal anti-prohibitin (1:1,000) (NBP7-40505, Novus
Biologicals, Cambridge, UK), mouse monoclonal anti-
TSG101 (1:1,000) (sc-7964, Santa Cruz, Santa Cruz,
CA, USA) and mouse monoclonal anti-a-tubulin
(1:4,000) (T5168, Sigma). Secondary antibodies coupled
to horseradish peroxidase were obtained from Amersham
Pharmacia Biotech (Diegem, Belgium). Immunoelectron
microscopy was performed with a primary mouse mono-
clonal anti-CD63 antibody (clone H5C6) (557305, Becton
Dickinson) and a rabbit anti-mouse IgG (Zymed Labora-
tories, San Francisco, CA, USA). OptiPrepTM was pur-
chased from Axis-Shield PoC (Oslo, Norway). Total
Exosome IsolationTM and ExoQuick-TCTM were pur-
chased from Invitrogen and System Biosciences respec-
tively. TNFa was obtained from R&D Systems
(Minneapolis, MN, USA).
Preparation of CM
CM was prepared from 3108 cells grown at 70% con-
fluency in T175 cell culture flasks. Cell cultures were
washed 3 times using DMEM followed by 24 hours
incubation with 15 mL exosome-harvesting medium at
378C and 10% CO2. Exosome-harvesting medium is
DMEM supplemented with 0.5% exosome-depleted foetal
bovine serum (EDS). EDS was obtained through 18 hours
centrifugation of foetal bovine serum at 100,000 g and
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subsequent filtering through a 0.2-mm filter (Whatman,
Dassel, Germany). Residual EV contamination was neg-
ligible since no protein or particles could be retrieved
from the exosomal gradient fractions after ODG centri-
fugation of 150-fold concentrated 0.5% EDS medium
(data not shown). CM was harvested and centrifuged
for 10 minutes at 200 g and 48C to remove detached
cells, followed by a 0.45 mm cellulose acetate filtration
(Corning, New York, USA) to remove larger particles.
Next, CM was concentrated approximately 200 times
using a Centricon† Plus-70 centrifugal filter device with a
10 K nominal molecular weight limit (Millipore, MA,
USA). The resulting 4 mL concentrated CM (CCM) was
filtered through a 0.2 mm cellulose acetate filter (Whatman)
and 1 mL was used for each exosome isolation method.
Following collection of the medium, cell cultures were
trypsinized and cell viability was measured on a Countess
Automatic Cell Counter (Invitrogen) using a 0.1% trypan
blue exclusion test. In addition, absence of apoptotic
cells was evaluated through analysis of PARP cleavage
(Supplementary Fig. 1).
Ultracentrifugation
One millilitre of CCM was diluted to 5 mL in phosphate
buffered saline (PBS) (Invitrogen), transferred to a 5.2 mL
open top polyallomer centrifuge tube (Beckman Coulter,
Fullerton, CA) and centrifuged for 3 hours at 100,000 g
and 48C in a swinging bucket centrifuge (Optima XPN-
80, SW 55 Ti rotor, Beckman Coulter). The pellet was
resuspended in 50 mL of PBS and stored at 808C. Note:
(a) in this protocol the 10,000 g. Hence it has no meaning
anymore in this section. Centrifugation step was omitted
due to the prior use of 0.45 and 0.2 mm filters to obtain the
CCM, and (b) no extra washing step was carried out in
regard to recently published observations (11).
OptiPrepTM density gradient centrifugation
A discontinuous iodixanol gradient was used as described
by (12) with some modifications. Solutions of 5, 10, 20 and
40% iodixanol were made by mixing appropriate amounts
of a homogenization buffer [0.25 M sucrose, 1 mM EDTA,
10 mM Tris-HCL, (pH 7.4)] and an iodixanol working
solution. This working solution was prepared by combin-
ing a working solution buffer [0.25 M sucrose, 6 mM
EDTA, 60 mM Tris-HCl, (pH 7.4)] and a stock solution
of OptiPrepTM (60% (w/v) aqueous iodixanol solution).
The gradient was formed by layering 4 mL of 40%, 4 mL
of 20%, 4 mL of 10% and 3.5 mL of 5% solutions on
top of each other in a 16.8 mL open top polyallomer
tube (Beckman Coulter). One millilitre CCM sample was
overlaid onto the top of the gradient which was then
centrifuged for 18 hours at 100,000 g and 48C (SW 32.1 Ti
rotor, Beckman Coulter). Gradient fractions of 1 mL were
collected from the top of the gradient, diluted to 16 mL
in PBS and centrifuged for 3 hours at 100,000 g and 48C.
The resulting pellets were resuspended in 100 mL PBS and
stored at 808C. To estimate the density of each fraction,
a standard curve was made of the absorbance values
at 340 nm of 1:1 aqueous dilutions of 5, 10, 20 and 40%
iodixanol solutions. This standard curve was used to
determine the density of fractions collected from a control
gradient overlaid with 1 mL of PBS.
ExoQuick-TCTM precipitation
ExoQuick-TCTM was used according to manufacturer’s
instructions (System Biosciences). Briefly, 1 mL of CCM
was diluted to 5 mL in PBS and mixed with 1 mL of
ExoQuick-TCTM solution by inverting the tube. The
sample was incubated overnight at 48C after which it
was spun down twice at 1,500 g for 30 and 5 minutes,
respectively. The supernatant was discarded and the pellet
was resuspended in 50 mL of PBS and stored at 808C.
TEI precipitation
TEI was used according to manufacturer’s instructions
(Invitrogen). Briefly, 1 mL of CCM was diluted to 5 mL in
PBS and mixed with 2.5 mL of TEI solution by repeated
pipetting. The sample was incubated overnight at 48C
and spun down for 1 hour at 10,000 g and 48C. The
supernatant was discarded and the pellet was resuspended
in 100 mL of PBS and stored at 808C.
Protein analysis
To measure protein concentration of isolated exosomes,
5 mL sample was mixed with 5 mL of Laemmli lysis buffer
[0.125 M TrisHCl (pH 6.8), 10% glycerol, 2.3% sodium
dodecyl sulphate (SDS)]. Protein concentration was deter-
mined using the Bio-Rad DC Protein Assay (Bio-Rad,
Hercules, USA). For analysis, 10 mg of protein was sus-
pended in reducing sample buffer [1 M TrisHCl (pH 6.8),
30% glycerol, 6% SDS, 3% 2-mercaptoethanol, 0.005%
bromophenol blue] or non-reducing sample buffer (with-
out 2-mercaptoethanol) and boiled for 5 minutes at
958C. Proteins were separated by SDS-PAGE (SDS-
polyacrylamide gel electrophoresis) and transferred to
polyvinylidene fluoride membranes, blocked in 5% non-
fat milk in PBS with 0.5% Tween-20, and immunostained.
Alternatively, separated proteins were stained with 0.5%
Coomassie Brilliant Blue (Bio-Rad) in 40% methanol and
10% acetic acid for 90 minutes and destained in a solution
composed of 40% methanol and 10% acetic acid.
Immunoelectron microscopy
Isolated exosomes were deposited on Formvar carbon-
coated, glow-discharged grids. After 20 minutes, the grids
were incubated in a blocking serum containing 1% BSA
in PBS. Antibodies and gold conjugates were diluted in
1% BSA in PBS. The grids were exposed to the primary
anti-CD63 antibody for 20 minutes, followed by sec-
ondary antibody to rabbit anti-mouse IgG (Zymed,
San Francisco, CA, USA) for 20 minutes and protein
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A-gold complex [10 nm size (13)] (CMC Utrecht, The
Netherlands) for 20 minutes. The efficiency of blocking
was controlled by performing the labelling procedure
in the absence of the primary antibody. The grids were
stained with neutral uranylacetate and embedded in
methylcellulose/uranyl acetate and examined in a Tecnai
Spirit transmission electron microscope (FEI, Eindhoven,
The Netherlands). Images were captured by Quemesa
charge-coupled device camera (Olympus Soft Imaging
Solutions GMBH, Munster, Germany).
Nanoparticle tracking analysis
Nanoparticle tracking analysis (NTA) was performed
using a NanoSight LM10-HS microscope (NanoSight
Ltd., Amesbury, UK) equipped with a 405 nm laser and an
automatic syringe pump system. Three 60-second videos
were recorded of each sample with camera level and
detection threshold set at 10. Temperature was monitored
throughout the measurements. Videos recorded for each
sample were analysed with NTA software version 2.3 to
determine the concentration and size of measured parti-
cles with corresponding standard error. For analysis,
auto settings were used for blur, minimum track length
and minimum expected particle size. The NanoSight
system was calibrated with polystyrene latex microbeads
of 50, 100, and 200 nm (Thermo Scientific, Fremont,
USA) prior to analysis. PBS was used to dilute the starting
material.
RNA analysis
Total RNA was isolated from exosome samples using the
miRNeasy Micro kit according to manufacturer’s instruc-
tions (Qiagen, Valencia, CA, USA). RNA concentration
was measured using a UV-Vis spectrophotometer (Nano-
drop Technologies, Wilmington, DE, USA). The Experion
electrophoresis system using the standard RNA chips
(Bio-Rad) was used to assess RNA quality and create
electropherograms. Whole genome mRNA expression
profiling was performed using a custom gene expres-
sion microarray (Agilent Technologies, Amstelveen, The
Netherlands). In brief, 10 ng of total RNA was labelled
using the Low Input Quick Amp labelling kit (Agilent) ac-
cording to the manufacturer’s instructions. Cy-3-labelled
cRNA was hybridized and probe intensities were analysed
using an Agilent microarray scanner and Feature Extrac-
tion software. Probe intensities were background sub-
tracted and normalized using Quantile normalization. For
downstream data analysis, only probes with a normalized
signal at least 2-fold above that of the negative control
probe (DarkCorner) were labelled as expressed. Probes
were included if expressed in all 3 replicates of 1 method.
For gene-level analysis, the probe with the highest mean
expression value for that gene across all samples was used.
Validation of differentially expressed genes was performed
via quantitative real-time polymerase chain reaction
(PCR) (RT-qPCR) using PrimePCRTM assays (Bio-Rad).
The 10.0-mL PCR reaction mix contained PrimePCR
Assay (0.5 mL), SsoAdvanced SYBR Green Supermix
(5.0 mL), cDNA (1 mL corresponding to the cDNA reverse
transcribed from approximately 10 ng RNA), and nuclease-
free water (4.5 mL). The 384-well plate was then run on
the CFX 384 (Bio-Rad) at 958C for 30 seconds, then 958C
for 5 seconds and 608C for 15 seconds (for 45 cycles).
PrimePCR assays that were used for qPCR are listed in
Supplementary Table 1. Data were processed and normal-
ized using qbase2.6 software (www.biogazelle.com).
Assays with too low an expression level (i.e. missing values
in multiple samples) were excluded. Three reference genes
(CYB5A, RCL1 and SYNGR2) were selected based on
geNorm analysis including 6 candidate genes with low
standard deviation across all samples in the microarray
experiment.
Gene set enrichment analysis was performed on mRNA
lists, ranked according to mean fold change between
methods using Gene Ontology biological process and
KEGG pathways as gene set collections (14). Alterna-
tively, functional annotation of enriched genes was deter-
mined using the DAVID bioinformatics database (15).
Hierarchical clustering was performed using Manhattan
distance and Ward clustering.
LC-MS/MS
Exosome samples were suspended in reducing sample
buffer (Novex† Tris-Glycine sample buffer, Invitrogen)
and boiled for 2 minutes at 858C. Samples were run on
Novex† 420% Tris-Glycine gradient gels (Invitrogen) in
denaturing SDS buffer, stained with 0.5% Coomassie
Brilliant Blue (Bio-Rad) in 40% methanol and 10% acetic
acid for 20 minutes, and destained in a solution composed
of 40% methanol and 10% acetic acid. Gel bands were
processed and analysed by liquid chromatographymass
spectrometry/mass spectrometry (LC-MS/MS) as pre-
viously described (16). Raw MS/MS files were submitted
to the NIH MASCOT Cluster (17) using MASCOT
DAEMON version 2.2. Data were searched against the
UNIPROT-SPROT database, updated on 20/05/08 as
described (16). For each peptide identification, MASCOT
reports a probability-based ion score, which is defined
as 10log10(P), where P is the absolute probability
that the observed match between the experimental data
and the database sequence is a random event. The signi-
ficance threshold for inclusion of each peptide in the
output file is the individual ion score meeting or exceeding
its MASCOT identity score threshold (pB0.05). Peptides
with ion scores below their identity scores were rejected.
MASS SIEVE was used to calculate percentage coverage
for each protein identification (http://www.ncbi.nlm.nih.
gov/staff/slottad/MassSieve). Peptide identifications from
1 representative experiment are shown.
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Results
Exosome markers are most enriched in ODG
exosome preparations
Exosomes were prepared from pre-purified CM derived
from non-apoptotic Rab27B-expressing MCF-7 cells
using 4 methods: UC, OptiPrepTM density gradient ultra-
centrifugation (ODG), ExoQuickTM solution (EQ) and
TEI solution (TEI) (Fig. 1). In all experiments, cell via-
bility was 95%, which is in accordance with the generally
accepted percentage to avoid potential contribution of
apoptotic bodies to the exosome preparations (Supple-
mentary Fig. 1) (18,19). Since fractions 8 and 9 obtained
from the ODG method, corresponding to a buoyant
density of 1.094 g/mL, were characterized by a high
number of particles as measured by NTA and high CD63
expression as assessed by Western blot, a pool of both
fractions was used (Supplementary Fig. 2). This density
is comparable to earlier publications on exosomes iso-
lated from cancer cells using an OptiPrepTM gradient
(2024). Western blot analysis demonstrated elevated
levels of exosomal marker proteins (Alix, HSP90a,
HSP70, TSG101 and CD63) in lysates from the centrifu-
gation-based (UC and ODG) compared to the precipita-
tion solution-based methods (EQ and TEI) (Fig. 2a).
Of note, increased protein concentrations were required
to identify CD63 in lysates from EQ and TEI (Fig. 2b,
lower panel). All exosome preparations were clear from
contaminating cell organelles as indicated by the absence
of markers of peroxisomes (PMP70), mitochondria (pro-
hibitin), Golgi apparatus (GM130) or endoplasmic reti-
culum and apoptotic bodies (calreticulin) as opposed to
total lysate of MCF-7 Rab27B cells (Fig. 2b).
Exosome preparations display morphological and
quantitative differences
Exosome preparations obtained by UC, ODG, EQ and
TEI were loaded onto carbon-coated grids and analysed
by immunoelectron microscopy with an anti-CD63 anti-
body recognizing an epitope either in the small or
large extracellular loop (EC1 or EC2) (25) (Fig. 3a and
Supplementary Fig. 3). Samples isolated using ODG were
Fig. 1. Schematic overview of 4 methods to isolate exosomes from conditioned medium (CM). Approximately 3108 MCF-7 Rab27B
cells were grown for 24 hours in DMEM containing 0.5% exosome-depleted serum. The CM was harvested, centrifuged, filtrated and
concentrated. The concentrated conditioned medium (CCM) was equally divided over 4 isolation methods: ultracentrifugation (UC),
OptiPrepTM density gradient centrifugation (ODG), ExoQuick-TCTM precipitation (EQ) and Total Exosome IsolationTM precipitation
(TEI).
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characterized by a typically heterogeneous exosomal
population consisting of abundant CD63-positive and a
few CD63-negative exosomes with a size range between
35 and 100 nm in diameter. The other 3 methods resulted
in the isolation of sparsely dispersed CD63-positive exo-
somes, larger and smaller vesicles clumped together, and
background contaminants.
Next, NTA revealed the sharpest size distribution
curves for UC and ODG, with 10% more particles
outside the 50150 nm range in EQ and TEI, indicating
more homogeneous preparations in the two former
methods (Fig. 3b). Mean particle sizes (160 nm) were
higher than those measured by TEM. As previously
reported, this difference can be explained by the fact that
NTA measures the hydrodynamic diameter of particles
and is inherently biased towards larger particles (26,27).
ODG isolated approximately 2-fold less particles com-
pared to UC and TEI, and 5-fold less compared to EQ
(Fig. 3b). Combined with the protein marker analysis
and immunoelectron microscopy data, this indicates
co-isolation of non-exosomal particles by EQ, TEI and
UC.
Isolation methods affect protein yield and profile
Protein yield, expressed as relative protein amount per
108 particles, was 2-fold less in exosome preparations from
ODG compared to UC. By contrast, EQ and TEI con-
tained respectively 3 and 8 times more protein per 108
particles than UC. Per 106 cells, ODG and UC protocols
typically harvested respectively 0.3 and 0.7 mg protein,
compared to an excessive amount of 5 mg by precipi-
tation techniques. Coomassie brilliant blue staining of
proteins, separated under reducing conditions by SDS-
PAGE, revealed a distinct protein profile with multiple
unique protein bands for ODG (Fig. 4b). LC-MS/MS.
Analysis of 2 selected bands in EQ identified contaminat-
ing serum proteins albumin and apolipoprotein E, while
these could not be detected in ODG samples (Fig. 4c). The
characteristic 69 kDa albumin band was also present
in UC and TEI. By contrast, Coomassie brilliant blue
staining of top-to-bottom fractions from ODG identifies
albumin mainly in top fractions 1 to 3 (Supplementary
Fig. 4).
ODG exosome preparations are characterized by a
unique mRNA profile
Compared to UC, the relative amount of RNA per 108
particles was almost 1.5-fold lower for EQ and TEI and
100-fold lower for ODG (Fig. 5). Per 106 cells, the RNA
yield was typically 0.7 ng for ODG, while being con-
siderably higher for UC (40 ng), EQ (75 ng) and TEI
(50 ng). Experion analysis for RNA yield and size of 3
replicates for each method (2 technical and 1 biological)
showed no signs of ribosomal 18S and 28S peaks, indi-
cating that the RNA present was not derived from cells or
debris (Fig. 5b). RNA of 1001,500 nucleotides (nt) was
enriched in UC, EQ and TEI, whereas the ODG sample
contained a small RNA population (less than 500 nt)
with a lower yield (Fig. 5b).
Fig. 2. Characterization of exosome preparations by Western blot. Western blot analysis of (a) common exosome markers (Alix,
HSP90a, HSP70, TSG101 and CD63) and (b) cell organelle and apoptosis markers (GM130, PMP70, calreticulin and prohibitin) in
10 mg of exosomes isolated by 4 different methods. MCF-7 Rab27B total cell lysate (TCL) was loaded as positive control. Asterisks
indicate loading of 50 mg of protein.
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Fig. 3. Morphological characterization and quantification of exosome preparations by immunoelectron microscopy and Nanoparticle
Tracking Analysis. (a) Electron micrographs of exosomes stained with 10 nm gold-conjugated anti-CD63 antibody followed by uranyl
acetate counterstaining. Scale bar: 100 nm. (b) Exosome samples were analysed using Nanoparticle Tracking Analysis. The calculated
size distribution is depicted as a mean (black line) with standard error (red shaded area). Total particle number, mean particle size and
modus are shown for each preparation.
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To examine the variations in RNA content due to
technical, biological and methodological effects, we per-
formed gene expression microarray profiling. Expression
correlation analysis revealed that the overall reproduci-
bility within UC, ODG and EQ was high with Spearman
rho-values between 0.78 and 0.97 (Supplementary Fig. 5a
and b). For TEI, the technical reproducibility was obser-
ved to be poor which led us to exclude this technique
in further analyses (Supplementary Fig. 6). When com-
paring the variations among the different methods, we
found striking differences between UC, ODG and EQ
with Spearman rho-values down to 0.40 (Supplementary
Fig. 5b).
To further evaluate technical, biological and meth-
odological variations, we performed an unsupervised
hierarchical clustering using mRNAs detected in all
replicates of at least 1 of 3 methods (UC, ODG, EQ)
(Fig. 6a). The heatmap showed 1) technical and biologi-
cal reproducibility for UC, ODG and EQ, and 2) a clear
differential clustering of ODG in 1 group, and UC and
EQ in a second group. When evaluating mRNA expres-
sion differences between methods, UCEQ showed a
Gaussian distribution with a negligible mean expression
difference of 0.020 [95% confidence interval: 0.001 to
0.034] whereas ODGUC and ODGEQ showed a
bimodal distribution revealing a fraction of genes with
higher and lower abundance in ODG versus UC and EQ
(Fig. 6b). Looking at the total number of mRNAs
detected over all methods, about 40% was shared between
all of them. Almost 30% of the mRNAs were exclusive to
Fig. 4. Analysis of the protein content of exosome preparations. (a) Relative level of protein per 108 particles in each preparation. Error
bars indicate relative standard error of two experiments. (b) Coomassie blue staining of 20 mg of MCF-7 Rab27B total cell lysate (TCL)
or exosome samples separated by SDS-PAGE. (c) Number of unique peptides and corresponding percentage coverage for indicated
proteins identified in MS analysis of an EQ exosome sample.
Fig. 5. Identification of the RNA content in exosome preparations. (a) Relative level of RNA per 108 particles in each preparation.
Error bars indicate relative standard error of two experiments. (b) Representative electropherograms of exosome samples generated
using the Experion system. Insets show RNA band pattern.
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ODG samples, while UC and EQ had only around 6%
unique mRNAs. UC and EQ had a mutual overlap
of over 80%, while ODG shared only about 65% of its
detected mRNAs with the other methods (Fig. 6c).
ODG samples are enriched in mRNA related to
translation, ribosome and mitochondrion functions
To better understand the biological significance of our
data, we performed a pathway enrichment analysis and
Gene Set Enrichment Analysis (Fig. 7a and b). When
running DAVID analysis on genes overrepresented in
ODG versus UC, functions related to translation, ribo-
some, mitochondrion and nuclear lumen were very sig-
nificantly enriched (Fig. 7a). These findings were further
validated by means of a GSEA analysis identifying gene
sets related to translation and ribosome as significantly
enriched in ODG compared to UC (Fig. 7b). Similar
results were obtained when comparing ODG versus EQ,
Fig. 6. Agilent microarray-based RNA profiling of exosome samples. (a) Heatmap showing unsupervised hierarchical clustering of
samples. Code from blue (2 log2 normalized expression) to red (2 log2 normalized expression) indicates RNA expression levels.
NB: Replicates 1 and 2 are technical, 3 is biological. (b) Plot showing mean expression difference and corresponding density of probes
for the 3 different methods. (c) Venn diagram of unique and shared mRNAs in UC, ODG and EQ samples.
Fig. 7. Identification of enriched genes in exosome RNA samples. (a) Scatter plot showing mean RNA expression in UC versus ODG
samples and indicating enriched GO terms according to DAVID analysis. (b) Gene Set Enrichment Analysis of UC versus ODG.
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while no enrichment analysis was performed on UC and
EQ because of their strong correlation (data not shown
and Supplementary Fig. 7a and b).
RT-qPCR validates microarray data for 10 selected
genes
RT-qPCR for the 6 most enriched genes in UC and EQ
and the 4 most enriched genes in ODG validated the
microarray generated data (Fig. 8a and b): (a) technical
and biological reproducibility was the highest for ODG,
and (b) relative expression levels as measured by RT-
qPCR followed those as analysed by microarray for
ODG, UC and EQ. This again showed the consistency
of ODG which has a similar expression of each investi-
gated RNA as opposed to UC and EQ where consider-
ably more variation occurs between replicates.
RNA-binding proteins are confounding contaminants
of exosome preparations
Based on the RNA data, we hypothesized that all methods
except ODG co-isolate RNA of non-exosomal origin,
possibly stabilized in protein complexes. We analysed the
presence of Argonaute-2 (Ago2) protein, a member of the
RNA-induced silencing complex and a well-characterized
extracellular RNA-binding protein (28,29), in all exosome
preparations by Western blot analysis (Fig. 9a). Ago2 was
detected in UC, EQ and TEI, while it was absent in ODG.
Furthermore, the presence of Ago2 was inversely cor-
related with the presence of exosome marker TSG101
(Fig. 9a). This was further confirmed on EQ and ODG
exosome preparations from a control MCF-7 cell line
not manipulated for increased exosome release (Supple-
mentary Fig. 8). Western blot analysis on top-to-bottom
fractions from ODG identified Ago2 in the non-exosomal
upper fractions 2, 3 and 4 (Fig. 8b).
Discussion
To accurately define the exosome-specific proteome,
transcriptome, glycome and lipidome, and thus under-
stand the functional significance of intercellular exosomal
communication, there is a growing need for standardized
and validated isolation methods to obtain pure exosomes.
This is a main topic of interest for exosome researchers
worldwide, as illustrated by recent position papers by the
International Society for Extracellular Vesicles (19,30).
Although previous studies comparing exosome isolation
methods were published, these mainly focused on the
proteome of isolated preparations, and never included
increasingly used precipitation solutions (12,31). Here,
for the first time, we assessed the impact of isolation
method, including precipitation methods, on (m)RNA.
We evaluated 4 commonly used methods for yield, size,
morphology, and protein and RNA content of exosome
preparations. Pros and cons of the different methods
are listed in Table I. We found that all methods were
able to isolate exosomes, as illustrated by Western blot
analysis and immunoelectron microscopy for exosome
markers. However, we demonstrated using complemen-
tary techniques that ODG obtains the purest exosome
preparations for downstream omics profiling. Multiple
observations indicate that UC, EQ and TEI do not
selectively enrich for exosomes but also co-isolate con-
taminating factors.
CD63-immuno-TEM showed clean exosome prepara-
tions for UC and ODG, whereas background contami-
nants were clearly visible in EQ and TEI images. Smaller,
3040 nm-sized CD63-positive vesicles could be seen in
UC and ODG, but were absent in EQ and TEI (Supple-
mentary Fig. 3). These observations point out that pre-
cipitation solutionbased techniques do not succeed in
extracting all exosomal particles from CM, while they do
co-precipitate non-exosomal impurities.
Western blot analysis showed that UC and particularly
ODG preparations were more enriched in exosomal
marker proteins, despite harvesting considerably less
protein than EQ and TEI. Accordingly, higher overall
protein yield by precipitation techniques is not an indi-
cation of higher exosome yields, but a consequence of
contaminating non-exosomal proteins. Thus, although
the absence of cell organelle markers is useful to exclude
cell lysis and apoptosis, these markers are insufficient to
rule out contaminating factors such as soluble proteins,
protein aggregates, chylomicrons and other vesicles. In our
study, 0.5% EDS medium was used to avoid induction
of apoptosis, cellular stress, and subsequent changes in
exosome content. Therefore, besides the cell’s own non-
exosomal secretome, a potential source for these contami-
nants is residual bovine serum, as it has been reported that
510% of secretome proteins and nanovesicles possibly
originates from serum (32).
Coomassie blue staining of the overall protein content
from EQ and TEI preparations showed a distinct pattern
compared to UC and especially ODG, supporting the
differences in protein isolation. Furthermore, it revealed
that ODG is the only technique capable of minimiz-
ing serum albumin contamination. MS-assisted proteome
analysis revealed the presence of serum albumin and
apolipoprotein E as contaminants in the EQ preparation.
The presence of soluble proteins and protein complexes
and aggregates in exosome preparations should therefore
be verified using markers such as albumin and apolipo-
proteins. Coomassie blue staining of all ODG fractions
shows an efficient removal of serum albumin in the top
fractions of the gradient (Supplementary Fig. 4). This
observation is consistent with a recent study on plasma
exosomes describing OptiPrepTM gradient centrifugation
as the only technique capable of eliminating contaminat-
ing plasma proteins (31). Non-vesicular proteins, predo-
minantly high molecular weight proteins and protein
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aggregates, co-sedimenting with exosomes in UC have
been reported previously as well (12). This contamination
increases with prolonged centrifugation time, predomi-
nantly when centrifuging longer than 4 hours (33). As
mentioned earlier, different protocols of differential UC
have been used to date, and we cannot exclude that
Fig. 8. RT-qPCR validation of mRNA expression. Normalized expression level of 6 genes with the lowest expression (a), and 4 genes
with the highest expression (b) in ODG compared to UC and EQ according to the performed microarray. Plotted values represent
3 replicates for each method.
Impact of EV isolation methods on RNA profiling
Citation: Journal of Extracellular Vesicles 2014, 3: 24858 - http://dx.doi.org/10.3402/jev.v3.24858 11
(page number not for citation purpose)
alternative centrifugation steps, including a 10,000 g spin
and washing steps of the exosome pellet, could help
reducing contamination of the exosome pellet.
NTA-mediated quantification of isolated particle num-
bers revealed that UC, EQ and TEI isolated 2- to 5-fold
more particles than ODG. Since ODG contained more
CD63-positive exosomes and was most enriched in exo-
somal marker proteins, as exemplified by IEM and
Western blotting, respectively, these particles are of
non-exosomal origin. However, no differences in mean
size were detected between preparations. This indicates
that sizing via NTA alone is not sufficient to rule out con-
tamination of exosome preparations with particles with
a similar hydrodynamic diameter such as chylomicrons
or protein complexes.
Microarray-based comparison of extracted RNA re-
vealed a distinct mRNA profile of ODG compared to
UC and EQ exosome preparations. It has been shown that
the choice of isolation technique can cause substantial
differences in isolated proteome (12) and according to
our data the impact on transcriptome is even more
profound. Unfortunately, ODG is implemented by a
very limited number of groups in the exosome research
field, and only once has it been used for transcriptomics
(12,2024,31,3440). Extracellular RNA shows remark-
able stability in an RNase rich environment, most likely
by encapsulation in membrane-bound vesicles such as
exosomes or by binding to protein complexes such as the
ribonucleoprotein Ago2. Although the presence of limited
amounts of Ago2 in exosomes has been reported (41), the
enrichment of Ago2 in all exosome preparations except
ODG suggests a potential contamination by protein/RNA
complexes. The fact that EQ precipitates Ago2 complexes
while ODG does not was confirmed on a cell line showing
basal secretion of exosomes (Supplementary Fig. 8).
While it does have an mRNA-binding pocket, until now
Ago2 is only known to form an extracellular complex with
miRNAs (29,42). Therefore, it remains unclear whether it
could contribute to the discrepancy in mRNA profiles
between exosome samples and this should be investigated
in the future. Nonetheless, the observation that an RNA
binding protein is predominantly found in UC, EQ and
TEI samples is another indication for contamination
of these preparations with non-exosomal complexes of
protein and/or RNA, thus hampering detection of exoso-
mal RNA of interest. In agreement, the purest exosome
preparation contains 100-fold less total RNA compared
to UC and EQ exosome pellets. Collection of different
gradient fractions showed that Ago2 and RNA with a size
ranging from 100 to 500 nt are predominantly present
in the upper fractions (Supplementary Fig. 9), corre-
sponding to less dense, soluble protein/RNA complexes.
Our data indicate that Ago2 could be a promising
candidate marker to evaluate contamination of exosome
preparations.
Fig. 9. Ago2 protein expression analysis. (a) Western blot results for Ago2 and TSG101 expression in each exosome preparation.
(b) Individual fractions of an OptiPrepTM gradient were lysed, separated by SDS-PAGE, and tested for the presence of Ago2 and
TSG101 by Western blot.
Table I. Characteristics of exosome isolation methods
Technique Purity Exosome yield Protein yield RNA yield Ease-of-use Turn-around time (h) Hands-on-time (h) Cost (t)
UC      4 B1 5
ODG      20 1 15
EQ      13 B0.5 15
TEI      13 B0.5 5
Comparison of the 4 methods in terms of purity (i.e. based on combined IEM, Western blotting, Coomassie blue staining and MS results),
exosome yield (i.e. based on IEM), protein and RNA yield, ease-of-use, turn-around time, hands-on time and approximate cost per
sample (i.e. based on cost of centrifuge tubes and required solutions). Legend: low; moderate; high; very high.
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Choice of isolation method had a profound impact on
the identification of enriched pathways and gene sets in
the samples. The enrichment of mRNAs with ribosomal,
nuclear and mitochondrial functions in the purest exo-
some fractions (ODG) from breast cancer cells comes as
no surprise since cancer cells show an increased cellular
metabolism and proliferation, necessitating an abundance
of mRNAs sustaining the metabolic needs for prolifera-
tion. Enrichment of mRNA related to ribosomes and
mitochondria in exosomes has been indicated in previous
studies (4345). Whether exosomes should be conside-
red as cellular waste containers acting to discard high
abundant molecular components is a point of intensive
research. Our data underpin the possible role of exosomes
as powerful biomarkers.
A proper isolation method is crucial to unravel
exosome-specific functions and biomarkers. We have
shown that 1) ODG outperforms the commonly imple-
mented methods UC, EQ and TEI in terms of purity and
consequently also exosome-specific protein and RNA
yield; and 2) the choice of isolation method severely
impacts downstream RNA profiling. In this study, we
have not compared the performance of sucrose-based
density gradients versus OptiPrepTM, although we would
expect it to be similar because both have the same mode
of action. To what extent specific pre-processing and
centrifugation steps, such as concentrating the medium,
applying pressure-driven filtration or performing a 10,000 g
spin, could influence the performance of different tech-
niques is beyond the present study but should be in-
vestigated in the future.
We strongly recommend considering and validating
isolation methods of choice to avoid confounding results
regarding exosome-specific content, functions and bio-
markers. Since ODG is the most labour-intensive method
(see Table I), we propose a workflow where newly iden-
tified functions and biomarkers are at least validated on
exosome preparations obtained by density gradient UC.
Finally, we encourage researchers to adequately address
the quality of exosome preparations and to report experi-
mental details in a transparent manner that permits
replication with the aim to increase the availability of
consistent and biologically relevant data.
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